FDA Inspection 1153894 — Rocky Mountain Apothecary
The FDA completed an inspection of Rocky Mountain Apothecary on Sep 10, 2021 in Bozeman, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 10, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bozeman, MT (United States)